SarkoLife:在接受多模式软组织肉瘤治疗的患者中改善生活质量
Sebastian Hoffmann1, Tabea Hoffmann2, Vlatko Potkrajcic3
1Department of Hand, Plastic, Reconstructive and Burn Surgery, BG Trauma Center Tuebingen, University of Tuebingen, Schnarrenbergstraße 95, Tuebingen, 72076, Germany.
World journal of surgical oncology
|January 8, 2025
概括
化疗显著影响软组织肉瘤患者的生活质量和痛苦水平,远远超过放射治疗或手术. 了解这些差异对于明智的治疗决策和患者护理至关重要.
科学领域:
- 在瘤学瘤学.
- 患者报告的结果
- 癌症治疗方法 癌症治疗方法
背景情况:
- 多式疗法是软组织肉瘤的标准治疗方法.
- 评估患者的生活质量和痛苦对于治疗优化至关重要.
研究的目的:
- 评估软组织肉瘤患者不同多式疗法方法的耐受性.
- 通过辐射,化疗和手术来比较生活质量和痛苦水平.
主要方法:
- 一项回顾性队列研究分析了2017-2022年期间治疗的237名软组织肉瘤患者的数据.
- 在线调查使用EORTC QLQ-C30和应急温度计来评估患者报告的结果.
- 用单向ANOVA比较治疗组之间的生活质量和痛苦得分.
主要成果:
- 在治疗方式之间观察到生活质量 (p<0.001) 和痛苦水平 (p<0.001) 的显著差异.
- 化疗患者报告生活质量最低 (平均26.8) 和痛苦最高 (平均7.4).
- 与放射治疗 (87.4%) 和化疗 (73.5%) 相比,患者重复治疗的意愿在手术 (94.2%) 中最高.
结论:
- 化疗与软组织肉瘤患者对生活质量产生更大的负面影响和增加痛苦有关.
- 与化疗相比,辐射和手术在生活质量和痛苦方面似乎可以更好地容忍.
- 这些发现需要在软组织肉瘤的患者同意和治疗规划过程中仔细考虑.
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...